Choose Your News
Loading...
The FDA has approved privately held NeuroSigma's Monarch eTNS System for the first-line treatment of patients ages 7 - 12 years old with attention deficit... [Read More]
The FDA grants final approval for Teva Pharmaceutical Industries' (TEVA) generic version of Adapt Pharma's NARCAN Nasal Spray (naloxone HCl), an opioid rev... [Read More]
On the heels of its announcement of positive preliminary results from its Phase 3 STR1VE study evaluating gene therapy candidate Zolgensma (onasemnogene ab... [Read More]
A Phase 3 clinical trial, Study A4091058, evaluating two strengths of Pfizer (PFE) and collaboration partner Eli Lilly's (LLY) tanezumab in patients with m... [Read More]
ContraVir Pharmaceuticals (CTRV) slips 2% after hours in reaction to its planned offering of 9,615,384 Class A Units and 2,500 Class B Units. Each Class A... [Read More]
Edwards Lifesciences (EW) has closed its $100M acquisition of CAS Medical Systems (CASM). It announced the deal two months ago. [Read More]
Intuitive Surgical (ISRG) Q1 results ($M): Revenue: 973.7 (+14.9%); Instruments & accessories: 552.3 (20.0%); Systems: 247.5 (+5.5%); Services: 173.9 (+13. [Read More]
The FDA approves Akorn's (AKRX) generic version of GlaxoSmithKline's (GSK) allergy med Flonase (fluticasone propionate). It also has an agreement with Inno... [Read More]
Thinly traded Magellan Health ([[MGLN]] +4%) is up on 70% higher volume, albeit on turnover of only 524K shares, on the heels of a post... [Read More]
Thinly traded micro cap Mustang Bio ([[MBIO]] +124.1%) is up on a whopping 420x surge in volume in reaction to positive results from a Phase... [Read More]
Acting on FDA feedback, Corbus Pharmaceuticals ([[CRBP]] -1.9%) has changed the primary endpoint of its Phase 3 clinical trial, RESOLVE-1, evaluating lead... [Read More]
Vaping and cannabis consumption products distributor Greenlane Holdings ([[GNLN]] N/A) opened at $29 per share today, over 70% higher than its IPO price of... [Read More]
AngioDynamics ([[ANGO]] -5.6%) slips on average volume in early trade on the heels of revised guidance accounting for the divestment of its NAMIC unit to... [Read More]
Cannabis producers Tilray ([[TLRY]] +1%), Cronos Group ([[CRON]] +4.5%) and Aurora Cannabis ([[ACB]] +0.8%) are enjoying a modest spike in buying on the he... [Read More]
Canopy Growth (CGC) has agreed to acquire Acreage Holdings (ACRGF) for $300M in cash plus 0.5818 CGC common shares for each Acreage subordinate voting shar... [Read More]
Amyris (AMRS) has sold its Vitamin E royalty agreement to Koninklijke DSM N.V. for ~$57M, completing its exit from the business. The parties have also... [Read More]
Nano cap Actinium Pharmaceuticals (ATNM) prices its public offering of ~42.9M common shares and five-year warrants to purchase up to the same number of sha... [Read More]
In a note, Raymond James' Jayson Bedford says Abbott (ABT) "should be a near-perfect stock for this [Medicare for all] environment" citing its above-averag... [Read More]
Mylan N.V. (MYL) will collaborate with non-profit drug developer TB Alliance to advance a new drug called pretomanid in two combination regimens to treat t... [Read More]
Thinly traded nano cap DelMar Pharmaceuticals (DMPI) has filed a prospectus for a non-transferable subscription rights offering of Units for shareholders a... [Read More]
Loading...
Preview